Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Combined treatment with low-dose interferon plus vinblastine is associated with less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma.

Tsavaris N, Skarlos D, Bacoyiannis C, Aravantinos G, Kosmas C, Retalis G, Panopoulos C, Vadiaka M, Dimitrakopoulos A, Kostantinidis K, Mitropoulos D, Bougas D, Pantazopoulos D, Kosmidis P.

J Interferon Cytokine Res. 2000 Aug;20(8):685-90.

PMID:
10954911
2.

A combination of vinblastine and doxorubicin with interferon alpha.

Jekunen A, Pyrhönen S.

Am J Clin Oncol. 1996 Aug;19(4):384-5.

PMID:
8677910
3.

An outpatient phase II study of subcutaneous interleukin-2 and interferon-alpha-2b in combination with intravenous vinblastine in metastatic renal cell cancer.

Pectasides D, Varthalitis J, Kostopoulou M, Mylonakis A, Triantaphyllis D, Papadopoulou M, Dimitriadis M, Athanassiou A.

Oncology. 1998 Jan-Feb;55(1):10-5.

PMID:
9428369
4.

Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III study.

Fosså SD, Martinelli G, Otto U, Schneider G, Wander H, Oberling F, Bauer HW, Achtnicht U, Holdener EE.

Ann Oncol. 1992 Apr;3(4):301-5.

PMID:
1390305
5.

Limited efficacy of interferon-alpha and vinblastine as second line biochemotherapy regimen in patients with progressive metastatic renal cell carcinoma.

Lopez Hanninen E, Fenner M, Kirchner H, Deckert M, Duensing S, Menzel T, Poliwoda H, Atzpodien J.

Cancer Biother. 1993 Winter;8(4):301-6.

PMID:
7804371
7.

Recombinant alpha-interferon and vinblastine in metastatic renal cell carcinoma: efficacy of low doses.

Cetto GL, Franceschi T, Turrina G, Chiarion-Sileni V, Capelli MC, Bellini A, Paccagnella A, Bassetto MA, Molino AM, de Sandre G.

Semin Surg Oncol. 1988;4(3):184-90. Review.

PMID:
3055162
8.

Vinblastine and interferon-alpha-2a regimen in the treatment of metastatic renal cell carcinoma.

Palmeri S, Gebbia V, Russo A, Gebbia N, Rausa L.

Tumori. 1990 Feb 28;76(1):64-5.

PMID:
2321276
9.

Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.

Figlin RA, deKernion JB, Maldazys J, Sarna G.

Cancer Treat Rep. 1985 Mar;69(3):263-7.

PMID:
3978656
10.

Metastatic renal cell cancer treated with recombinant alpha 2a interferon and vinblastine.

Massidda B, Migliari R, Padovani A, Scarpa RM, Pellegrini P, Cortesi E, Usai E, Pellegrini A.

J Chemother. 1991 Dec;3(6):387-9.

PMID:
1819623
12.

A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma.

Mittelman A, Huberman M, Puccio C, Fallon B, Tessitore J, Savona S, Eyre R, Gafney E, Wick M, Skelos A, et al.

Cancer. 1990 Aug 15;66(4):664-9.

13.

Interleukin-2, interferon-alpha and interleukin-2 plus interferon-alpha in renal cell carcinoma. A randomized phase II trial.

Boccardo F, Rubagotti A, Canobbio L, Galligioni E, Sorio R, Lucenti A, Cognetti F, Ruggeri E, Landonio G, Baiocchi C, Besana C, Citterio G, De Rosa M, Calabresi F.

Tumori. 1998 Sep-Oct;84(5):534-9.

PMID:
9862512
14.

Combined chemo-immuno-hormonotherapy of advanced renal cell carcinoma.

Panetta A, Martoni A, Guaraldi M, Tamberi S, Casadio M, Lelli G, Pannuti F.

J Chemother. 1994 Oct;6(5):349-53.

PMID:
7861200
16.

Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.

Dutcher JP, Logan T, Gordon M, Sosman J, Weiss G, Margolin K, Plasse T, Mier J, Lotze M, Clark J, Atkins M.

Clin Cancer Res. 2000 Sep;6(9):3442-50.

17.
18.

Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials.

Bacoyiannis C, Dimopoulos MA, Kalofonos HP, Nicolaides C, Aravantinos G, Bafaloukos D, Samelis G, Onyenadum A, Kiamouris Ch, Skarlos D, Pavlidis N, Triantafillidis A, Kosmidis P; Hellenic Cooperative Oncology Group..

Oncology. 2002;63(2):130-8.

PMID:
12239447
19.
20.

Interferon-alpha, 5-FU and prednisone in metastatic renal cell carcinoma: a phase II study.

Haarstad H, Jacobsen AB, Schjølseth SA, Risberg T, Fosså SD.

Ann Oncol. 1994 Mar;5(3):245-8.

PMID:
8186172

Supplemental Content

Support Center